These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 21813044)

  • 21. Significant elevation of plasma matrix metalloproteinase-9 level and its ratio to matrix metalloproteinase-2 in patients with pelvic inflammatory disease.
    Wang PH; Tsai HT; Tee YT; Lin LY; Yang SF; Hsieh YS
    Fertil Steril; 2009 Nov; 92(5):1679-84. PubMed ID: 18937938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationships between circulating matrix metalloproteinase-2 and -9 and renal function in patients with chronic kidney disease.
    Chang HR; Yang SF; Li ML; Lin CC; Hsieh YS; Lian JD
    Clin Chim Acta; 2006 Apr; 366(1-2):243-8. PubMed ID: 16313894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of gelatinase and tumor necrosis factor-α level in the vitreous and serum of patients with Eales disease: role of inflammation-mediated angiogenesis in the pathogenesis of Eales disease.
    Sen A; Paine SK; Chowdhury IH; Mukherjee A; Choudhury S; Mandal LK; Bhattacharya B
    Retina; 2011; 31(7):1412-20. PubMed ID: 21394064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum levels of matrix metalloproteinase-2 and -9 in patients with head and neck squamous cell carcinoma.
    Riedel F; Götte K; Schwalb J; Hörmann K
    Anticancer Res; 2000; 20(5A):3045-9. PubMed ID: 11062721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Matrix metalloproteinases in serum of Emery-Dreifuss muscular dystrophy patients.
    Niebroj-Dobosz I; Madej-Pilarczyk A; Marchel M; Sokołowska B; Hausmanowa-Petrusewicz I
    Acta Biochim Pol; 2009; 56(4):717-22. PubMed ID: 19997654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Negative association between serum levels of matrix metalloproteinases-2 and -9 and aortic stiffness in healthy adults.
    Vlachopoulos C; Aznaouridis K; Dima I; Ioakeimidis N; Vasiliadou C; Zervoudaki A; Gialernios T; Stefanadis C
    Int J Cardiol; 2007 Nov; 122(3):232-8. PubMed ID: 17289174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sensitivity and specificity of ELISA and immunoblot for diagnosing neurocysticercosis.
    Gekeler F; Eichenlaub S; Mendoza EG; Sotelo J; Hoelscher M; Löscher T
    Eur J Clin Microbiol Infect Dis; 2002 Mar; 21(3):227-9. PubMed ID: 11957028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relation of matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio in peripheral circulating CD14+ monocytes to progression of coronary artery disease.
    Brunner S; Kim JO; Methe H
    Am J Cardiol; 2010 Feb; 105(4):429-34. PubMed ID: 20152234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interferon-beta-1 b decreased matrix metalloproteinase-9 serum levels in primary progressive multiple sclerosis.
    Yushchenko M; Mäder M; Elitok E; Bitsch A; Dressel A; Tumani H; Bogumil T; Kitze B; Poser S; Weber F
    J Neurol; 2003 Oct; 250(10):1224-8. PubMed ID: 14586607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation of matrix metalloproteinases-2 and -9 with proinflammatory cytokines in Guillain-Barré syndrome.
    Nyati KK; Prasad KN; Verma A; Paliwal VK
    J Neurosci Res; 2010 Dec; 88(16):3540-6. PubMed ID: 20936699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated circulating levels of matrix metalloproteinase-9 and -2 in patients with symptomatic coronary artery disease.
    Zeng B; Prasan A; Fung KC; Solanki V; Bruce D; Freedman SB; Brieger D
    Intern Med J; 2005 Jun; 35(6):331-5. PubMed ID: 15892761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of an IgG-ELISA strategy using Taenia solium metacestode somatic and excretory-secretory antigens for diagnosis of neurocysticercosis revealing biological stage of the larvae.
    Sahu PS; Parija SC; Narayan SK; Kumar D
    Acta Trop; 2009 Apr; 110(1):38-45. PubMed ID: 19183550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinase-4 in cerebrospinal fluid with blood-brain barrier dysfunction in patients with eosinophilic meningitis caused by Angiostrongylus cantonensis.
    Tsai HC; Chung LY; Chen ER; Liu YC; Lee SS; Chen YS; Sy CL; Wann SR; Yen CM
    Am J Trop Med Hyg; 2008 Jan; 78(1):20-7. PubMed ID: 18187780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of serum matrix metalloproteinase-2 and -9 to predict breast cancer progression.
    Patel S; Sumitra G; Koner BC; Saxena A
    Clin Biochem; 2011 Jul; 44(10-11):869-72. PubMed ID: 21565179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dynamic contrast-enhanced (DCE) MRI derived kinetic perfusion indices may help predicting seizure control in single calcified neurocysticercosis.
    Singh AK; Garg RK; Gupta RK; Malhotra HS; Agrawal GR; Husain N; Pandey CM; Sahoo P; Kumar N
    Magn Reson Imaging; 2018 Jun; 49():55-62. PubMed ID: 29366682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relative seroprevalence of cysticercus antigens and antibodies and antibodies to Taenia ova in a population sample in south India suggests immunity against neurocysticercosis.
    Jayaraman T; Prabhakaran V; Babu P; Raghava MV; Rajshekhar V; Dorny P; Muliyil J; Oommen A
    Trans R Soc Trop Med Hyg; 2011 Mar; 105(3):153-9. PubMed ID: 21216417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in patients with relapsing-remitting multiple sclerosis treated with interferon beta.
    Boz C; Ozmenoglu M; Velioglu S; Kilinc K; Orem A; Alioglu Z; Altunayoglu V
    Clin Neurol Neurosurg; 2006 Feb; 108(2):124-8. PubMed ID: 16412833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis.
    Kanyama M; Kuboki T; Kojima S; Fujisawa T; Hattori T; Takigawa M; Yamashita A
    J Orofac Pain; 2000; 14(1):20-30. PubMed ID: 11203734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Matrix metalloproteinases 2 and 9 as diagnostic markers in the progression to Chagas cardiomyopathy.
    Bautista-López NL; Morillo CA; López-Jaramillo P; Quiroz R; Luengas C; Silva SY; Galipeau J; Lalu MM; Schulz R
    Am Heart J; 2013 Apr; 165(4):558-66. PubMed ID: 23537973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mesocestoides corti intracranial infection as a murine model for neurocysticercosis.
    Alvarez JI; Mishra BB; Gundra UM; Mishra PK; Teale JM
    Parasitology; 2010 Mar; 137(3):359-72. PubMed ID: 20109250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.